Volume 27, Number 7—July 2021
CME ACTIVITY - Research
Non–C. difficile Clostridioides Bacteremia in Intensive Care Patients, France
Table 3
Characteristics of non–C. difficile bacteria in cases of Clostridioides bacteremia, France
Characteristic | No. (%) patients |
||||||
---|---|---|---|---|---|---|---|
All patients, n = 135 |
Survived, n = 65 |
Died in ICU, n = 70 |
|||||
Clostridium species | |||||||
Perfringens | 42 (31) | 16 (25) | 26 (37) | ||||
Ramosum | 18 (13) | 10 (15) | 8 (11) | ||||
Any Clostridioides sp. | 16 (12) | 6 (9) | 10 (14) | ||||
Tertium | 14 (10) | 9 (14) | 5 (7) | ||||
Clostridiforme | 12 (9) | 8 (12) | 4 (6) | ||||
Septicum | 10 (7) | 2 (3) | 8 (11) | ||||
Innocuum | 6 (4) | 5 (8) | 1 (1) | ||||
Butyricum | 4 (3) | 2 (3) | 2 (3) | ||||
Paraputrificum | 3 (2) | 2 (3) | 1 (1) | ||||
Baratii | 2 (1) | 1 (2) | 1 (1) | ||||
Orbiscindens | 2 (1) | 1 (2) | 1 (1) | ||||
Sporogenes | 2 (1) | 1 (2) | 1 (1) | ||||
Cadaveris | 1 (1) | 0 (0) | 1 (1) | ||||
Novyi | 1 (1) | 1 (2) | 0 (0) | ||||
Sordellii | 1 (1) | 0 (0) | 1 (1) | ||||
Symbosium |
1 (1) |
1 (2) |
0 (0) |
||||
No. positive blood cultures for Clostridioides spp. | |||||||
1 | 117 (87) | 52 (80) | 65 (93) | ||||
2 | 13 (10) | 9 (14) | 4 (6) | ||||
3 |
5 (4) |
4 (6) |
1 (1) |
||||
Other microbes associated with Clostridioides bacteremia, n = 49 | 27 | 22 | |||||
Gram-negative bacteria | 33 (67) | 20 (74) | 13 (59) | ||||
Gram-positive bacteria | 24 (49) | 12 (44) | 12 (55) | ||||
Candida fungemia |
1 (2) |
1 (4) |
0 (0) |
||||
Effectiveness of tested antimicrobial drugs against Clostridioides species | |||||||
Penicillin, n = 84 | 83 (99) | 37 (100) | 46 (98) | ||||
Clindamycin, n = 67 | 46 (69) | 22 (67) | 24 (71) | ||||
Vancomycin, n = 67 | 67 (100) | 33 (100) | 34 (100) | ||||
Metronidazole, n = 84 |
82 (98) |
36 (97) |
46 (98) |
||||
Patients receiving drugs | 110 (91) | 64 (98) | 46 (82) | ||||
Beta-lactams | 102 (94) | 60 (94) | 42 (95) | ||||
Amoxicillin/clavulanic acid | 9 (9) | 6 (10) | 3 (7) | ||||
Piperacillin/tazobactam | 46 (45) | 25 (42) | 21 (50) | ||||
Cephalosporins | 22 (22) | 15 (25) | 7 (17) | ||||
Carbapenems | 26 (25) | 15 (25) | 11 (26) | ||||
Aminoglycoside | 58 (54) | 34 (53) | 24 (55) | ||||
Anti–gram positive bacteria | 46 (43) | 29 (45) | 17 (39) | ||||
Metronidazole | 39 (36) | 26 (41) | 13 (30) | ||||
Others | 10 (9) | 5 (8) | 5 (11) | ||||
Missing data |
2 |
0 |
2 |
||||
Origin of bacteremia | |||||||
Digestive origin | 87 (74) | 43 (70) | 44 (79) | ||||
Bowel pathology | 33 (28) | 14 (23) | 19 (34) | ||||
Mesenteric ischemia | 25 (21) | 7 (11) | 18 (32) | ||||
Peritonitis | 19 (16) | 16 (26) | 3 (5) | ||||
Pancreatic or biliary origin | 10 (9) | 6 (10) | 4 (7) | ||||
Myonecrosis | 19 (16) | 11 (18) | 8 (14) | ||||
Abscess | 8 (7) | 5 (8) | 3 (5) | ||||
Pneumonia |
3 (3) |
2 (3) |
1 (2) |
||||
Missing data | 18 |
4 |
14 |